Link to this page
The Prescription of Drugs Ontology
| Preferred Name | Fosinopril | |
| Synonyms |
(S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid (2S,4S)-4-cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid (2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid fosinopril (4S)-4-cyclohexyl-1-({[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)-L-proline Fosinopril |
|
| Definitions |
A phosphinate ester-containing N-acyl derivative of (4S)-cyclohexyl-L-proline. It is used for the treatment of hypertension and heart failure. A pro-drug, it is hydrolysed in vivo to the corresponding phosphininc acid, fosinoprilat, which is the active metabolite. |
|
| ID |
http://purl.obolibrary.org/obo/CHEBI_5163 |
|
| alternative term |
(S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid (2S,4S)-4-cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid (2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid fosinopril (4S)-4-cyclohexyl-1-({[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)-L-proline Fosinopril
|
|
| bearer_of |
http://purl.obolibrary.org/obo/CHEBI_35674 |
|
| charge |
0
|
|
| database_cross_reference |
PMID:8285178 CAS:98048-97-6 PMID:22729889 LINCS:LSM-6485 KEGG:C07016 Patent:CN101367839 Patent:US4337201 Patent:EP2264039 PMID:9195116 PMID:11937741 DrugBank:DB00492 Beilstein:8176492 Patent:US2010297711 KEGG:D07992 PMID:18209565
|
|
| formula |
C30H46NO7P
|
|
| has functional parent | ||
| has role |
http://purl.obolibrary.org/obo/CHEBI_35674 |
|
| has_alternative_id |
CHEBI:159901 CHEBI:288733
|
|
| has_exact_synonym |
(4S)-4-cyclohexyl-1-({[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)-L-proline Fosinopril
|
|
| has_obo_namespace |
chebi_ontology
|
|
| has_related_synonym |
(S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid (2S,4S)-4-cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid (2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid fosinopril
|
|
| has_RxCUI |
50166
|
|
| id |
CHEBI:5163
|
|
| in_subset | ||
| inchi |
InChI=1S/C30H46NO7P/c1-4-28(33)37-30(22(2)3)38-39(36,18-12-11-15-23-13-7-5-8-14-23)21-27(32)31-20-25(19-26(31)29(34)35)24-16-9-6-10-17-24/h5,7-8,13-14,22,24-26,30H,4,6,9-12,15-21H2,1-3H3,(H,34,35)/t25-,26+,30?,39?/m1/s1
|
|
| inchikey |
BIDNLKIUORFRQP-FKDWWROVSA-N
|
|
| is bearer of | ||
| is conjugate acid of | ||
| label |
Fosinopril fosinopril
|
|
| mass |
563.66250
|
|
| monoisotopicmass |
563.30119
|
|
| notation |
CHEBI:5163
|
|
| prefixIRI |
CHEBI:5163
|
|
| prefLabel |
Fosinopril
|
|
| smiles |
[H][C@]1(C[C@H](N(C1)C(=O)CP(=O)(CCCCc1ccccc1)OC(OC(=O)CC)C(C)C)C(O)=O)C1CCCCC1
|
|
| textual definition |
A phosphinate ester-containing N-acyl derivative of (4S)-cyclohexyl-L-proline. It is used for the treatment of hypertension and heart failure. A pro-drug, it is hydrolysed in vivo to the corresponding phosphininc acid, fosinoprilat, which is the active metabolite.
|
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |